Day: April 30, 2026

us corporate news

Molson Coors Beverage Company Q1 2026 Financial Results and SEC Filings Overview

Minichart

April 30, 2026

Molson Coors Beverage Company Reports Q1 2026 Results: Solid...

Continue Reading 0

us corporate news

Vistance Networks Sells RUCKUS Networks to Belden for $1.85 Billion, Plans Special Shareholder Distribution

Minichart

April 30, 2026

Vistance Networks to Sell RUCKUS Networks Business to Belden...

Continue Reading 0

us corporate news

OneWater Marine Inc. Reports Improved Boat Margins and Reduced Leverage in Q2 2026 Financial Results

Minichart

April 30, 2026

OneWater Marine Inc. Reports Fiscal Q2 2026 Results – Key De...

Continue Reading 0

us corporate news

Cartesian Therapeutics Reports Q1 2026 Financial Results and Advances Descartes-08 Clinical Trials in Autoimmune Diseases

Minichart

April 30, 2026

Cartesian Therapeutics Reports Q1 2026 Results: Key Updates ...

Continue Reading 0

us corporate news

T. Rowe Price Group Q1 2026 Financial Results: Income, Fees, and Business Updates

Minichart

April 30, 2026

T. Rowe Price Group Reports Q1 2026 Earnings: Key Details fo...

Continue Reading 0

us corporate news

Eli Lilly Q1 2026 Earnings: Record Growth Driven by Zepbound and New Product Approvals

Minichart

April 30, 2026

Eli Lilly Reports Q1 2026 Results: Revenue and Earnings Surg...

Continue Reading 0

us corporate news

CNX Resources Q1 2026 Earnings Results: Production, Financials, Guidance & Free Cash Flow Highlights

Minichart

April 30, 2026

CNX Resources Reports Strong Q1 2026 Results and Updates Gui...

Continue Reading 0

us corporate news

Pyxis Oncology, Inc. Files Amended 8-K/A Report for 2026 with SEC – Company Details, Address, and Nasdaq Listing

Minichart

April 30, 2026

Pyxis Oncology, Inc. Announces CEO Departure and Separation ...

Continue Reading 0

us corporate news

Fermi Inc. Files Form 8-K with SEC Detailing Corporate Information and Compliance Status – April 29, 2026

Minichart

April 30, 2026

Fermi Inc. Files Form 8-K: Key Details for Investors Fer...

Continue Reading 0

us corporate news

Phathom Pharmaceuticals Reports Q1 2026 Results: VOQUEZNA Prescriptions Surge, Revenue Doubles, Operating Profitability Expected in Q3

Minichart

April 30, 2026

Phathom Pharmaceuticals Q1 2026 Financial Results: In-depth ...

Continue Reading 0

Day: April 30, 2026

Join Our Investing Seminar